VMA21: A Potential Drug Target and Biomarker for Neuron Development and Maintenance

Target Name: VMA21

NCBI ID: G203547

VMA21

VMA21: A Potential Drug Target and Biomarker for Neuron Development and Maintenance

VMA21 (Vitamin B12-Mannosylated Glycoprotein 21) is a protein that is expressed in various tissues of the body, including the nervous system, and is involved in the development and maintenance of the nervous system. It is also known as MGC125516, a potential drug target and biomarker.

The nervous system is a critical part of the body and is responsible for the development and maintenance of many functions, including movement, sensation, and communication. The nervous system is also affected by a variety of disorders, including those that affect cognitive function, such as Alzheimer's disease, Parkinson's disease, and other forms of dementia.

VMA21 is a protein that is expressed in the nervous system and is involved in the development and maintenance of the nervous system. It is also involved in the regulation of cellular processes that are important for the survival and function of neurons, as well as the formation of the myelin sheath that surrounds and supports neurons.

One of the functions of VMA21 is to regulate the level of a protein called BMP-2 (basic helix-loop-repeat protein 2), which is involved in the development and maintenance of neurons. BMP-2 is a potent stimulator of neuron growth and differentiation, and is involved in a variety of neurological disorders, including cancer, Alzheimer's disease, and other forms of dementia.

VMA21 is also involved in the regulation of the levels of other proteins that are important for the survival and function of neurons, including the neurotransmitter serotonin and the ion channels that regulate the flow of electrical signals through the nervous system.

In addition to its role in the nervous system, VMA21 is also a potential drug target and biomarker. Its expression is often reduced in the brains of individuals with neurodegenerative disorders, such as Alzheimer's disease and Parkinson's disease, and it is potential target for therapeutic intervention.

Studies have also shown that VMA21 is involved in a variety of cellular processes that are important for the development and maintenance of the nervous system. For example, VMA21 has been shown to be involved in the regulation of cellular signaling pathways that are important for the survival and function of neurons, as well as the formation of the myelin sheath that surrounds and supports neurons.

In conclusion, VMA21 is a protein that is expressed in various tissues of the body and is involved in the development and maintenance of the nervous system. It is also involved in the regulation of cellular processes that are important for the survival and function of neurons, as well as the formation of the myelin sheath that surrounds and supports neurons. Its potential as a drug target and biomarker makes it an attractive target for further research.

Protein Name: Vacuolar ATPase Assembly Factor VMA21

Functions: Required for the assembly of the V0 complex of the vacuolar ATPase (V-ATPase) in the endoplasmic reticulum

The "VMA21 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about VMA21 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets